Study On The Transformation And Upgrading Of The L Pharmaceutical Group

After 30 years of rapid development,the pharmaceutical industry in China has been expanding its scale and volume and significantly improving its position in the industry.However,with China's economic development entering a new normal,the new medical care has been transformed into the deep water area and the medical insurance dividend gradually disappears.The pharmaceutical industry is facing unprecedented growth pressure.Especially since 2015,under the guidance of the general idea of the linkage reform of the three medical institutions,the government has introduced a series of policies such as consistency assessment of generic drug quality and efficacy,two-vote system,reform of public hospitals,public hospital reform and medical insurance control fees And measures,pharmaceutical companies struggling to deal with miserably.The traditional business model and growth mode has been difficult to adapt to the needs of the new situation,and the strategic transformation and upgrading of enterprises is imperative.On the other hand,with the vigorous demand for health,active innovation and entrepreneurship,hot investment in capital and policies to encourage development,the health industry develops vigorously.The pharmaceutical companies are placed at the core of the health industry.The proximity of the waterfront to the hospitals and the layout of the large-scale health industry coincides with the great development.There is plenty of room for the strategic transformation and upgrading of the enterprises.Based on the theory of enterprise transformation and upgrading and strategic management theory,this paper comprehensively analyzes the macroscopic environment and industry environment of L Pharmaceutical Group through PEST analysis method and Porter Five-Force Competitiveness Model.Through political and legal environmental factors,economic operation factors,humanistic society Analysis of factors and scientific and technological factors can provide a guarantee for enterprises to formulate strategies for the transformation and upgrading.Through SWOT analysis,the advantages and disadvantages of the pharmaceutical group are summarized,and the opportunities and challenges coexist.The principles and planning of the transformation and upgrading strategy for the L Pharmaceutical Group will be further formulated.Finally,the safeguard measures for the transformation and upgrading of the pharmaceutical group will be determined.